The phytase market is on the brink of a new era. For the first time, it will be possible to replace all feed phosphate additives in pig and poultry diets. This is thanks to the launch of the next-level phytase RONOZYME® HiPhos by DSM Nutritional Products.

RONOZYME® HiPhos is the most powerful and active phytase in the global market. Extensive pre-launch trials with poultry and pigs in many countries have clearly proved its benefits. When added to livestock feed, it has the ability to consistently deliver nearly twice the level of available phosphorus from the widest range of feed raw materials as do current competitor phytase products. Feed formulations using RONOZYME® HiPhos therefore require considerably less inorganic phosphorus and/or animal protein producers. This noticeably cuts feed costs. It also significantly reduces the environmental impact of livestock farming, as less phosphorus is excreted by livestock on a diet containing RONOZYME® HiPhos. Dependent on feed ingredient prices and feed composition, trial results published show that additional savings of 10―15% can be generated compared to standard phytase recommendations.

RONOZYME® HiPhos has been jointly created by the DSM Novozymes Alliance, which has over 20 years of experience in the development of phytase and other enzymes for use in animal feed. Having already jointly developed the market-leading phytase RONOZYME® NP, DSM and Novozymes pooled their extensive knowledge and expertise to create the new RONOZYME® HiPhos.

Antonio Ruy Freire, President Animal Nutrition & Health at DSM Nutritional Products, comments: “The launch of RONOZYME® HiPhos shows the DSM Novozymes Alliance to be once again offering an excellent solution for unmet customer needs with this product evolution. This breakthrough heralds a new era in sustainable feeding and production in monogastric livestock. It means that feed producers can reduce their feeding costs, which makes them more profitable, while at the same time cutting their environmental impact.”

RONOZYME® HiPhos also offers greater efficiency in application. It comes in three forms. RONOZYME® HiPhos (GT) for pelleted feeds, featuring what DSM describes as the most heat-stable phytase available on the market. Its flowability, mixability and freedom from dust are excellent. Presented in granulated form, RONOZYME® HiPhos continues the DSM tradition of having the industry-leading thermo-stable, dust-free formulation with a particle size that ensures optimal distribution in premixes and feeds.
RONOZYME® HiPhos (M), meanwhile, is a more suitable product form for mash feed processing, whereas RONOZYME® HiPhos (L) is a liquid form for any other feed applications.

ENDS

About Novozymes
Novozymes is the world leader in bioinnovation. Together with customers across a broad array of industries, we create tomorrow’s industrial biosolutions, improving our customers' business and the use of our planet's resources. With over 700 products used in 130 countries, Novozymes’ bioinnovations improve industrial performance and safeguard the world’s resources by offering superior and sustainable solutions for tomorrow’s ever-changing marketplace. Novozymes’ natural solutions enhance and promote everything, from removing trans fats in food to advancing biofuels to power the world tomorrow. Our never-ending exploration of nature’s potential is evidenced by over 6,000 patents, showing what is possible when nature and technology join forces. Our 5,000+ employees working in research, production, and sales around the world are committed to shaping business today and our world tomorrow. Novozymes is quoted on NASDAQ OMX Copenhagen A/S. Read more at www.novozymes.com.

DSM – Bright Science. Brighter Living. ™
Royal DSM N.V. is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, pharmaceuticals, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials. DSM’s 22,000 employees deliver annual net sales of about € 9 billion. The company is listed on NYSE Euronext. More information can be found at www.dsm.com.

For more information:
DSM Nutritional Products
External Communications
Charlotte Frederiksen
tel. +41 61 815 83 54
fax +41 61 815 82 90
e-mail charlotte.frederiksen@dsm.com